nevirapine drug combination lamivudine stavudine

generic fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-vir) for treatment of advanced HIV infection

Also Known As:

stavudine, lamivudine, nevirapine drug combination; GPO-vir; stavudine - lamivudine - nevirapine; triomune

Networked: 16 relevant articles (3 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrimidines: 510
    - Pyrimidine Nucleosides: 50
      - Thymidine: 4460
        Stavudine: 696
        nevirapine drug combination lamivudine stavudine: 16
      - Cytidine: 535
        Deoxycytidine: 307
        Zalcitabine: 278
        Lamivudine: 3620
        nevirapine drug combination lamivudine stavudine: 16
  - Pyridines: 88
    - Nevirapine: 887
      - nevirapine drug combination lamivudine stavudine: 16
Nucleic Acids, Nucleotides, and Nucleosides: 1
- Nucleosides: 6847
  - Pyrimidine Nucleosides: 50
    - Thymidine: 4460
      - Stavudine: 696
        nevirapine drug combination lamivudine stavudine: 16
    - Cytidine: 535
      - Deoxycytidine: 307
        Zalcitabine: 278
        Lamivudine: 3620
        nevirapine drug combination lamivudine stavudine: 16
  - Deoxyribonucleosides: 34

Experts

1.	Desakorn, Varunee: 3 articles (11/2011 - 03/2005)
2.	Pitisuttithum, Punnee: 3 articles (11/2011 - 03/2005)
3.	Khoo, Saye: 2 articles (12/2014 - 12/2009)
4.	Dhitavat, Jittima: 2 articles (11/2011 - 09/2006)
5.	Aoudjane, Samir: 1 article (12/2014)
6.	Beloukas, Apostolos: 1 article (12/2014)
7.	Chaponda, Mas: 1 article (12/2014)
8.	Geretti, Anna Maria: 1 article (12/2014)
9.	González Del Castillo, Antonio Adrián: 1 article (12/2014)
10.	Hopkins, Mark: 1 article (12/2014)

Related Diseases

1.	HIV Infections (HIV Infection) 03/30/2007 - "Our results support the safety and effectiveness of the triomune combination for first-line treatment of HIV infection. " 09/01/2006 - "GPO-vir was well tolerated and effective in increasing CD4 cell count and suppressing plasma viremia in advanced HIV infection during the 48 weeks follow-up period." 09/01/2006 - "To assess the efficacy and safety of generic fixed-dose combination of stavudine, lamivudine and nevirapine; GPO-vir in advanced HIV infection. " 09/01/2006 - "Efficacy and safety of generic fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-vir) in advanced HIV infection."
2.	Opportunistic Infections (Opportunistic Infection) 11/01/2011 - "The occurrence of new opportunistic infections decreased significantly (p < 0.001) with GPO-VIR treatment. " 03/01/2005 - "The occurrence of opportunistic infections was significantly lower after treatment with GPO-VIR (p = 0.001). " 03/01/2005 - "The objectives of the study were to assess the efficacy of GPO-VIR by evaluating body weight changes, CD4 T-cell count changes, the occurrence of opportunistic infections, and long-term side effects, such as lipodystrophy, during treatment. "
3.	Lipodystrophy 11/01/2011 - "Thirty-six patients (27%) switched from GPO-VIR to other anti-retroviral drugs regimens due to lipodystrophy. " 03/01/2005 - "GPO-VIR is an inexpensive and effective antiretroviral drug regimen for initiating treatment of naïve patients, but careful assessment for lipodystrophy is necessary, especially after one year of treatment." 03/01/2005 - "Subjective assessment of lipodystrophy by physicians and patients showed that 16.8% had symptoms of lipodystrophy within 2 years of GPO-VIR treatment. " 03/01/2005 - "The objectives of the study were to assess the efficacy of GPO-VIR by evaluating body weight changes, CD4 T-cell count changes, the occurrence of opportunistic infections, and long-term side effects, such as lipodystrophy, during treatment. "
4.	Body Weight Changes 03/01/2005 - "The objectives of the study were to assess the efficacy of GPO-VIR by evaluating body weight changes, CD4 T-cell count changes, the occurrence of opportunistic infections, and long-term side effects, such as lipodystrophy, during treatment. "
5.	Viremia 09/01/2006 - "GPO-vir was well tolerated and effective in increasing CD4 cell count and suppressing plasma viremia in advanced HIV infection during the 48 weeks follow-up period."

Related Drugs and Biologics

1.	Nevirapine (Viramune)
2.	Lamivudine (Epivir)
3.	Stavudine (Zerit)
4.	nevirapine drug combination lamivudine stavudine
5.	Tablets
6.	Protease Inhibitors (Protease Inhibitor)
7.	Delavirdine (Rescriptor)
8.	Nelfinavir (Viracept)
9.	Indinavir (Crixivan)
10.	Ritonavir (Norvir)

Related Therapies and Procedures

1.	Therapeutics
2.	Aftercare (After-Treatment)